Matinas Biopharma logo

Matinas Biopharma Share Price Today

(NASDAQ: MTNB)

Matinas Biopharma share price is $0.63 & ₹55.08 as on 8 Feb 2025, 2.30 'hrs' IST

$0.63

0.05

(8.79%)

Market is closed - opens 8 PM, 10 Feb 2025

View live Matinas Biopharma share price in Dollar and Rupees. Guide to invest in Matinas Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Matinas Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Matinas Biopharma share price movements

  • Today's Low: $0.57
    Today's High: $0.67

    Day's Volatility :14.29%

  • 52 Weeks Low: $0.48
    52 Weeks High: $21.50

    52 Weeks Volatility :97.78%

Matinas Biopharma (MTNB) Returns

PeriodMatinas Biopharma Holdings IncIndex (Russel 2000)
3 Months
-29.89%
0.0%
6 Months
-91.78%
0.0%
1 Year
-94.02%
0.0%
3 Years
-98.23%
-13.5%

Matinas Biopharma (MTNB) Key Statistics

in dollars & INR

Previous Close
$0.58
Open
$0.5998
Today's High
$0.66505
Today's Low
$0.57
Market Capitalization
$3.0M
Today's Volume
$194.1K
52 Week High
$21.5
52 Week Low
$0.478
Revenue TTM
$0.0
EBITDA
$-23.4M
Earnings Per Share (EPS)
$-4.74
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-97.59%

How to invest in Matinas Biopharma Stock (MTNB) from India?

It is very easy for Indian residents to invest directly in Matinas Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Matinas Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Matinas Biopharma or MTNB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Matinas Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Matinas Biopharma shares which would translate to 1.388 fractional shares of Matinas Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Matinas Biopharma, in just a few clicks!

Returns in Matinas Biopharma (MTNB) for Indian investors in Rupees

The Matinas Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Matinas Biopharma investment value today

Current value as on today

₹11,303

Returns

₹88,697

(-88.7%)

Returns from Matinas Biopharma Stock

₹94,028 (-94.03%)

Dollar Returns

₹5,331 (+5.33%)

Indian investors sentiment towards Matinas Biopharma (MTNB)

87%

Period: Jan 9, 2025 to Feb 8, 2025. Change in 30 Days versus previous period

Search interest for Matinas Biopharma Stock from India on INDmoney has increased by 87% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Matinas Biopharma

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Matinas Biopharma(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Matinas Biopharma Stock (MTNB)

What analysts predicted

Upside of 4661.9%

Target:

$30.00

Current:

$0.63

Insights on Matinas Biopharma Stock (Ticker Symbol: MTNB)

  • Price Movement

    In the last 7 days, MTNB stock has moved up by 8.8%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.09M → -1.09M (in $), with an average decrease of 200.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -5.82M → -4.27M (in $), with an average increase of 17.8% per quarter
  • MTNB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.9% return, outperforming this stock by 156.7%
  • MTNB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 87.1% return, outperforming this stock by 185.4%

Matinas Biopharma Technicals Summary

Sell

Neutral

Buy

Matinas Biopharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Matinas Biopharma (MTNB) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Matinas Biopharma Holdings Inc logo
1.77%
-91.78%
-94.02%
-98.23%
-98.99%
Biontech Se logo
-4.27%
45.88%
25.3%
-29.8%
282.97%
Regeneron Pharmaceuticals, Inc. logo
1.88%
-36.67%
-25.03%
14.85%
78.95%
Vertex Pharmaceuticals Incorporated logo
14.59%
1.04%
12.14%
98.96%
89.39%
Alnylam Pharmaceuticals, Inc. logo
16.06%
2.22%
63.1%
83.08%
113.21%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Matinas Biopharma Holdings Inc logo
NA
NA
0.0
-4.06
-0.98
-0.51
NA
4.43
Biontech Se logo
160.8
NA
0.04
-3.29
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
18.83
18.83
1.15
43.84
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.28
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Matinas Biopharma Holdings Inc logo
Buy
$3.0M
-98.99%
NA
0.0%
Biontech Se logo
Buy
$28.8B
282.97%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$78.9B
78.95%
18.83
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$123.9B
89.39%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.9B
113.21%
NA
-15.86%

About Matinas Biopharma

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It also offers MAT2501, an orally administered formulation of amikacin to treat chronic and acute bacterial infections, as well as non-tuberculosis mycobacterium. The company has strategic collaborations with the National Institute of Allergy and Infectious Diseases for the development of oral formulations of Gilead's remdesivir; BioNTech SE to evaluate the combination of mRNA formats with the LNC platform; and Genentech Inc. to develop oral formulations. Matinas BioPharma Holdings, Inc. was incorporated in 2013 and is based in Bedminster, New Jersey.
Organization
Matinas Biopharma
Employees
32
CEO
Mr. Jerome D. Jabbour J.D.
Industry
Health Technology

Management People of Matinas Biopharma

NameTitle
Mr. Jerome D. Jabbour J.D.
Co-Founder, CEO, President & Director
Mr. Keith A. Kucinski CPA, M.B.A.
Chief Financial Officer
Mr. Frank Calamusa
Executive Director and Head of Manufacturing & Supply Chain

Important FAQs about investing in MTNB Stock from India :

What is Matinas Biopharma share price today?

Matinas Biopharma share price today stands at $0.63, Open: $0.60 ; Previous Close: $0.58 ; High: $0.67 ; Low: $0.57 ; 52 Week High: $21.50 ; 52 Week Low: $0.48.

The stock opens at $0.60, after a previous close of $0.58. The stock reached a daily high of $0.67 and a low of $0.57, with a 52-week high of $21.50 and a 52-week low of $0.48.

Can Indians buy Matinas Biopharma shares?

Yes, Indians can invest in the Matinas Biopharma (MTNB) from India.

With INDmoney, you can buy Matinas Biopharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Matinas Biopharma at zero transaction cost.

How can I buy Matinas Biopharma shares from India?

It is very easy to buy Matinas Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Matinas Biopharma (MTNB) be purchased?

Yes, you can buy fractional shares of Matinas Biopharma with INDmoney app.

What are the documents required to start investing in Matinas Biopharma stocks?

To start investing in Matinas Biopharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Matinas Biopharma Stock (MTNB)?

Today’s highest price of Matinas Biopharma (MTNB) is $0.67.

Today’s lowest price of Matinas Biopharma (MTNB) is $0.57.

What is today's market capitalisation of Matinas Biopharma?

Today's market capitalisation of Matinas Biopharma MTNB is 3.0M

What is the 52 Week High and Low Range of Matinas Biopharma Stock (MTNB)?

  • 52 Week High

    $21.50

  • 52 Week Low

    $0.48

What are the historical returns of Matinas Biopharma (MTNB)?

  • 1 Month Returns

    1.77%

  • 3 Months Returns

    -91.78%

  • 1 Year Returns

    -94.02%

  • 5 Years Returns

    -98.99%

Who is the Chief Executive Officer (CEO) of Matinas Biopharma ?

Mr. Jerome D. Jabbour J.D. is the current Chief Executive Officer (CEO) of Matinas Biopharma.